roxadustat

15 stories · following the connections

Business

FibroGen Reports Fourth Quarter and Full Year 2017 Financial Results

By Nasdaq OMXFeb 27, 2018, 9:11 PM UTC

Business

FibroGen Reports Third Quarter 2017 Financial Results

By Nasdaq OMXNov 8, 2017, 9:02 PM UTC

Business

FibroGen Announces Acceptance by China FDA of Roxadustat New Drug Application (NDA) for Treatment of Anemia Associated With Dialysis and Non-Dialysis Chronic Kidney Disease (CKD)

By Nasdaq OMXOct 18, 2017, 11:01 AM UTC

Business

About FibroGen, Inc.FibroGen to Present at the Goldman Sachs 38th Annual Global Healthcare Conference

By Nasdaq OMXJun 13, 2017, 11:00 AM UTC

Business

FibroGen Reports First Quarter 2017 Financial Results

By Nasdaq OMXMay 9, 2017, 8:05 PM UTC

Business

FibroGen Reports First Quarter 2017 Financial Results

By Nasdaq OMXMay 9, 2017, 8:05 PM UTC

Business

FibroGen Reports First Quarter 2017 Financial Results

By Nasdaq OMXMay 9, 2017, 8:05 PM UTC

Business

FibroGen Announces China FDA Approval of CTA to Conduct Pivotal Phase 2/3 Clinical Trial of Roxadustat in Anemia Associated With Lower Risk MDS

By Nasdaq OMXMar 31, 2017, 11:05 AM UTC